Asset Details
Do you wish to reserve the book?
Impact of Diabetes on Work Cessation: Data from the GAZEL cohort study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Impact of Diabetes on Work Cessation: Data from the GAZEL cohort study
Do you wish to request the book?
Impact of Diabetes on Work Cessation: Data from the GAZEL cohort study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Impact of Diabetes on Work Cessation: Data from the GAZEL cohort study
2011
Overview
OBJECTIVE: To measure the impact of diabetes on work cessation, i.e., on the risks of work disability, early retirement, and death while in the labor force. RESEARCH DESIGN AND METHODS: We used data from the GAZEL prospective cohort of 20,625 employees of the French national gas and electricity company \"EDF-GDF.\" We identified 506 employees with diabetes and randomly selected 2,530 nondiabetic employed control subjects matched for major sociodemographic and occupational characteristics. Using a multistate Cox model, we estimated hazard ratios (HRs) comparing the risks of transition from employment to disability, retirement, and death over time between participants with versus without diabetes. RESULTS: Employment rate decreased more rapidly in participants with diabetes (51.9 and 10.1% at 55 and 60 years, respectively) compared with nondiabetic participants (66.5 and 13.4%, respectively). Participants with diabetes had significantly increased risks of transition from employment to disability (HR 1.7 [95% CI 1.0-2.9]), retirement (HR 1.6 [1.5-1.8]), and death (HR 7.3 [3.6-14.6]) compared with participants without diabetes. Between 35 and 60 years, each participant with diabetes lost an estimated mean time of 1.1 year in the workforce (95% CI 0.99-1.14) compared with a nondiabetic participant. CONCLUSIONS: Our results provide evidence for a profound negative impact of diabetes on workforce participation in France. Social and economic consequences are major for patients, employers, and society--a burden that is likely to increase as diabetes becomes more and more common in the working-aged population.
Publisher
American Diabetes Association
Subject
/ Biological and medical sciences
/ Death
/ Diabetes
/ Diabetes Mellitus - economics
/ Diabetes Mellitus - mortality
/ Diabetes. Impaired glucose tolerance
/ Disabled Persons - statistics & numerical data
/ Endocrine pancreas. Apud cells (diseases)
/ Etiopathogenesis. Screening. Investigations. Target tissue resistance
/ Female
/ France
/ Humans
/ Male
/ patients
/ Public health. Hygiene-occupational medicine
/ Retirement - statistics & numerical data
/ Risk
/ society
/ Studies
/ Work
